NCT05173493

The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 670 (actual)
• Sponsor: Shandong University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The patients who accepted the quadruple eradication program of the helicobacter pylori but failed to eradicate helicobacter pylori will be assessed the most suitable re-eradication time of helicobacter pylori.

Detailed description

Helicobacter pylori (HP) infection is a common global infectious disease, which is an important cause of chronic gastritis, peptic ulcer and gastric cancer. At present, due to the non-standard Helicobacter pylori eradication program in clinical work, poor patient compliance and other reasons, the phenomenon of HP eradication treatment failure is more and more common. However, there is still no conclusion on the most appropriate time for remedial treatment inpatients with Hp eradication failure.

Conditions

• Helicobacter Pylori Infection

Interventions

Type	Name	Description
DRUG	Amoxicillin,Furazolidone	Amoxicillin-Furazolidone-containing quadruple group
DRUG	Amoxicillin,Levofloxacin	Amoxicillin-Levofloxacin-containing quadruple group
DRUG	Tetracycline,Furazolidone	Tetracycline-Furazolidone-containing quadruple group

Timeline

• Start date: 2021-12-30
• Primary completion: 2023-02-10
• Completion: 2023-02-10
• First posted: 2021-12-30
• Last updated: 2023-02-17

Locations

1 site across 1 country: China